Laurel Wealth Advisors (North Carolina)’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-3
Closed -$2K – 569
2022
Q2
$2K Hold
3
– – ﹤0.01% 533
2022
Q1
$2K Hold
3
– – ﹤0.01% 582
2021
Q4
$2K Hold
3
– – ﹤0.01% 582
2021
Q3
$3K Hold
3
– – ﹤0.01% 543
2021
Q2
$2K Buy
+3
New +$2.08K ﹤0.01% 665

Other funds holding GOSS

Laurel Wealth Advisors (North Carolina)'s GOSS Position: Q3 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 3 shares — an estimated $2K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in GOSS in Q2 2021 and held it in 5 quarters. The position peaked at $3K in Q3 2021. 157 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 3 Gossamer Bio shares in Q3 2022, an estimated $2K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Gossamer Bio in Q2 2021 and held it in 5 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Gossamer Bio position peaked at $3K in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2022, filed 15 Nov 2022.